
Figura Analytics is a Loughborough University spinout company specializing in liquid analysis. They leverage patented nanopore technology, combined with AI and DNA aptamers, to rapidly count and characterize particles in various liquids, providing a 'fingerprint' of the sample. Their technology is designed to improve product quality and consistency, identify contaminants, and build brand value. The entire analysis process takes less than an hour. Figura's technology has applications in diverse industries including Life Sciences, Food and Beverage, Healthcare, and Semi-Conductors. The company has received backing from SFC Capital, Innovate UK, and Angel Investors since its spinout in January 2021. Key team members include CEO Nick Whitehurst, and co-founders Dr. Mark Platt and Rhush Maugi.

Figura Analytics is a Loughborough University spinout company specializing in liquid analysis. They leverage patented nanopore technology, combined with AI and DNA aptamers, to rapidly count and characterize particles in various liquids, providing a 'fingerprint' of the sample. Their technology is designed to improve product quality and consistency, identify contaminants, and build brand value. The entire analysis process takes less than an hour. Figura's technology has applications in diverse industries including Life Sciences, Food and Beverage, Healthcare, and Semi-Conductors. The company has received backing from SFC Capital, Innovate UK, and Angel Investors since its spinout in January 2021. Key team members include CEO Nick Whitehurst, and co-founders Dr. Mark Platt and Rhush Maugi.
What they do: Nanopore-based platform that rapidly counts and characterises particles in liquid samples using microfluidics, sensors, ML and DNA aptamers
Founded / type: Loughborough University spinout (founded 2020)
Key markets: Drinks/Food & Beverage, Life Sciences, Healthcare, Pharmaceuticals, Semi‑conductors, Environmental monitoring
Team size (reported): 3 employees
Recent funding signals: Seed rounds led by SFC Capital (2021, 2023) and a Feb 2024 non‑equity assistance event (WorldUpstart); additional support from Innovate UK and angel investors
Quality control and contaminant detection in liquids across industries such as drinks, food & beverage, life sciences, healthcare, pharmaceuticals and semi‑conductors.
2020
Analytical instrumentation / Life sciences / Food & beverage testing
Recorded as non-equity assistance
“Received backing from SFC Capital, WorldUpstart, Innovate UK and angel investors”